Shopping Cart 0
Cart Subtotal
USD 0

Neomed Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Neomed Institute (Neomed) is a not-for-profit organization that provides drug discovery and development services. The organization spans its expertise in the development of small molecule therapeutics, biologics and vaccines. It offers chemistry, DMPK, fermentation and biology laboratories, decontamination & sterilization facilities, analytical and open-access NMR services. Neomed offers programs such as GPR120, for diabetes and metabolic disorder; NEO5937 for treatment of pain and respiratory indications; BRD4 for leukemia and breast cancers and others. The organization carries out research and development in partnership with The Institute for Research in Immunology and cancer commercialization of research, mitacs, Crocus Laboratories and epigeneti among others. Neomed is headquartered in Montreal, Quebec, Canada.

Neomed Institute-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Neomed Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Neomed Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Neomed Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Neomed Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Neomed Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Neomed Institute, Pharmaceuticals & Healthcare, Deal Details 10

Private Equity 10

Ampersand Capital Partners Invests NEOMED-LABS from NEOMED Institute 10

Partnerships 11

Axxam Partners with Neomed Institute 11

Neomed Institute Partners with McGill University 12

Univalor Partners with Centre de recherche du Centre hospitalier de l'Universite de Montreal and Neomed Institute 13

Epigenetix Partners with Neomed Institute 14

Licensing Agreements 15

Artelo Biosciences to Enter into Licensing Agreement with Neomed Institute 15

BELLUS Health Enters into Licensing Agreement with NEOMED Institute for BLU-5937 16

Neomed Institute-Key Competitors 17

Neomed Institute-Key Employees 18

Neomed Institute-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Product News 20

04/27/2017: BELLUS Health to present at Bloom Burton & Co. Healthcare Investor Conference 20

Clinical Trials 21

Sep 18, 2017: BELLUS Health's BLU-5937 Significantly Reduces Cough Without Taste Disturbance in Two Preclinical Models 21

Other Significant Developments 23

Sep 04, 2018: Ampersand invests in management buyout of clinical immunology provider NEOMED-LABS from the NEOMED Institute 23

Jun 05, 2018: Pfizer Canada Invests in the NEOMED Institute to Further Support Growth in Quebec's Life Sciences Sector 24

Appendix 25

Methodology 25

About GlobalData 25

Contact Us 25

Disclaimer 25


List Of Figure

List of Figures

Neomed Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Neomed Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Neomed Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Neomed Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Neomed Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Neomed Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Neomed Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Neomed Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Neomed Institute, Pharmaceuticals & Healthcare, Key Facts 2

Neomed Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Neomed Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Neomed Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Neomed Institute, Deals By Therapy Area, 2012 to YTD 2018 8

Neomed Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Ampersand Capital Partners Invests NEOMED-LABS from NEOMED Institute 10

Axxam Partners with Neomed Institute 11

Neomed Institute Partners with McGill University 12

Univalor Partners with Centre de recherche du Centre hospitalier de l'Universite de Montreal and Neomed Institute 13

Epigenetix Partners with Neomed Institute 14

Artelo Biosciences to Enter into Licensing Agreement with Neomed Institute 15

BELLUS Health Enters into Licensing Agreement with NEOMED Institute for BLU-5937 16

Neomed Institute, Key Competitors 17

Neomed Institute, Key Employees 18

Neomed Institute, Other Locations 19

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Neomed Institute, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.